IL130404A0 - Use of photodynamic therapy for prevention of secondary cataracts - Google Patents

Use of photodynamic therapy for prevention of secondary cataracts

Info

Publication number
IL130404A0
IL130404A0 IL13040497A IL13040497A IL130404A0 IL 130404 A0 IL130404 A0 IL 130404A0 IL 13040497 A IL13040497 A IL 13040497A IL 13040497 A IL13040497 A IL 13040497A IL 130404 A0 IL130404 A0 IL 130404A0
Authority
IL
Israel
Prior art keywords
prevention
photodynamic therapy
secondary cataracts
cataracts
photodynamic
Prior art date
Application number
IL13040497A
Other languages
English (en)
Original Assignee
Qlt Phototherapeutics Inc
Univ British Columbia
Ciba Vision Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Qlt Phototherapeutics Inc, Univ British Columbia, Ciba Vision Ag filed Critical Qlt Phototherapeutics Inc
Publication of IL130404A0 publication Critical patent/IL130404A0/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0057Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
    • A61K41/0071PDT with porphyrins having exactly 20 ring atoms, i.e. based on the non-expanded tetrapyrrolic ring system, e.g. bacteriochlorin, chlorin-e6, or phthalocyanines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • A61P27/12Ophthalmic agents for cataracts

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
IL13040497A 1996-12-10 1997-12-08 Use of photodynamic therapy for prevention of secondary cataracts IL130404A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/762,854 US6043237A (en) 1996-12-10 1996-12-10 Use of photodynamic therapy for prevention of secondary cataracts
PCT/CA1997/000949 WO1998025610A1 (en) 1996-12-10 1997-12-08 Use of green porphyrins for the manufacture of a medicament for the treatment of secondary cataracts

Publications (1)

Publication Number Publication Date
IL130404A0 true IL130404A0 (en) 2000-06-01

Family

ID=25066203

Family Applications (1)

Application Number Title Priority Date Filing Date
IL13040497A IL130404A0 (en) 1996-12-10 1997-12-08 Use of photodynamic therapy for prevention of secondary cataracts

Country Status (15)

Country Link
US (2) US6043237A (no)
EP (1) EP0948329A1 (no)
JP (1) JP2001505885A (no)
KR (1) KR20000057510A (no)
CN (1) CN1246054A (no)
AR (1) AR010754A1 (no)
AU (1) AU737204B2 (no)
CA (1) CA2273010C (no)
HU (1) HUP0000576A3 (no)
IL (1) IL130404A0 (no)
NO (1) NO992808L (no)
NZ (1) NZ336196A (no)
PL (1) PL333951A1 (no)
WO (1) WO1998025610A1 (no)
ZA (1) ZA9711104B (no)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0963196B1 (en) * 1996-09-27 2005-01-19 Jagotec Ag Hyaluronic drug delivery system
ES2237146T3 (es) 1998-08-28 2005-07-16 Destiny Pharma Limited Derivados de porfirina, su uso en terapia fotodinamica y dispositivos medicos que los contienen.
US6828439B1 (en) 1999-02-26 2004-12-07 Advanced Research And Technology Institute, Inc. Compounds, composition, and methods for photodynamic therapy
US7022843B1 (en) 1999-04-14 2006-04-04 The University Of British Columbia β,β′-dihydroxy meso-substituted chlorins, isobacteriochlorins, and bacteriochlorins
US6319273B1 (en) * 1999-12-16 2001-11-20 Light Sciences Corporation Illuminating device for treating eye disease
US6673067B1 (en) * 2000-01-31 2004-01-06 Gholam A. Peyman System and method for thermally and chemically treating cells at sites of interest in the body to impede cell proliferation
US7193706B2 (en) * 2000-08-02 2007-03-20 Arizona Board Of Regents, Acting On Behalf Of Arizona State University Computer interfaced scanning fluorescence lifetime microscope applied to directed evolution
US6514995B1 (en) 2000-09-25 2003-02-04 Advanced Research And Technology Institute, Inc. Enediyne compounds and methods related thereto
US7211603B1 (en) 2000-09-25 2007-05-01 Indiana University Research And Technology Corporation Enediyne compounds and methods related thereto
US7169755B2 (en) * 2000-12-20 2007-01-30 Alcon, Inc. Solution for removing cataracts via liquefracture
US7753943B2 (en) * 2001-02-06 2010-07-13 Qlt Inc. Reduced fluence rate PDT
US8106038B2 (en) 2001-02-15 2012-01-31 Qlt Inc. Method for reducing or preventing PDT related inflammation
US6838074B2 (en) 2001-08-08 2005-01-04 Bristol-Myers Squibb Company Simultaneous imaging of cardiac perfusion and a vitronectin receptor targeted imaging agent
EP1465590B1 (en) * 2001-11-02 2008-03-26 The Governors Of The University Of Alberta Micelle compositions containing pegylated phospholipids and a photosensitizer
US6723750B2 (en) 2002-03-15 2004-04-20 Allergan, Inc. Photodynamic therapy for pre-melanomas
JP4468810B2 (ja) 2002-07-24 2010-05-26 キューエルティー インコーポレーティッド ピラゾリルベンゾチアゾール誘導体および治療薬としてのそれらの使用法
CA2500877A1 (en) * 2002-10-03 2004-04-15 Light Sciences Corporation Excitation of photoreactive compounds in eye tissue
EP1605847B1 (en) * 2003-03-07 2009-09-16 Board Of Regents, The University Of Texas System Antibody-targeted photodynamic therapy
US20050048109A1 (en) * 2003-08-26 2005-03-03 Ceramoptec Industries, Inc. Non-polar photosensitizer formulations for photodynamic therapy
US7252662B2 (en) * 2004-11-02 2007-08-07 Lenticular Research Group Llc Apparatus and processes for preventing or delaying one or more symptoms of presbyopia
US7468434B2 (en) * 2004-12-22 2008-12-23 The University Of Hong Kong Diazene-bridge crown ether lithium compounds and methods for their use
US9649224B2 (en) 2005-02-19 2017-05-16 Lenticular Research Group Llc Apparatus and processes for preventing or delaying onset or progression of age-related cataract
US9622911B2 (en) 2010-09-30 2017-04-18 Cxl Ophthalmics, Llc Ophthalmic treatment device, system, and method of use
EP2802302A4 (en) * 2012-01-10 2015-09-23 Avedro Inc APPLYING ENERGY FOR MEDICAL TREATMENTS
EP4420725A2 (en) 2012-03-29 2024-08-28 Epion Therapeutics, Inc. Ocular treatment solutions, delivery devices and delivery augmentation methods
EP2830554A1 (en) * 2012-03-29 2015-02-04 CXL Ophthalmics, LLC Ocular cross-linking system and method for sealing corneal wounds
WO2013149075A1 (en) 2012-03-29 2013-10-03 Cxl Ophthalmics, Llc Compositions and methods for treating or preventing diseases associated with oxidative stress
CN106620893B (zh) 2015-07-23 2021-07-30 爱博诺德(北京)医疗科技股份有限公司 用于眼部疾病光治疗的材料
US20230165718A1 (en) * 2021-11-29 2023-06-01 Alan Neil Glazier Methods, devices, and systems for treating lens protein aggregation diseases

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5202252A (en) * 1982-03-05 1993-04-13 Houston Biotechnology Inc. Monoclonal antibodies against lens epithelial cells and methods for preventing proliferation of remnant lens epithelial cells after extracapsular extraction
US5283255A (en) * 1987-01-20 1994-02-01 The University Of British Columbia Wavelength-specific cytotoxic agents
US5095030A (en) * 1987-01-20 1992-03-10 University Of British Columbia Wavelength-specific cytotoxic agents
US5171749A (en) * 1987-01-20 1992-12-15 University Of British Columbia Wavelength-specific cytotoxic agents
US4920143A (en) * 1987-04-23 1990-04-24 University Of British Columbia Hydro-monobenzoporphyrin wavelength-specific cytotoxic agents
US5401880A (en) * 1987-06-04 1995-03-28 Oculon Corporation Chemical prevention or reversal of cataract by phase separation inhibitors
US4966577A (en) * 1988-03-16 1990-10-30 Allergan, Inc. Prevention of lens-related tissue growth in the eye
US5273751A (en) * 1988-03-25 1993-12-28 Seymour Dubroff Composition for preventing clouding of paosterior capsule after extracapsular cataract eye surgery and method of performing cataract surgery
US5375611A (en) * 1993-01-26 1994-12-27 Pharmacia Ab Method for preventing secondary cataract
US5422362A (en) * 1993-07-29 1995-06-06 Quadra Logic Technologies, Inc. Method to inhibit restenosis
US5445637A (en) * 1993-12-06 1995-08-29 American Cyanamid Company Method and apparatus for preventing posterior capsular opacification
AU6813694A (en) * 1994-03-14 1995-10-03 Massachusetts Eye & Ear Infirmary Use of green porphyrins in ocular diagnosis and therapy
US5798349A (en) * 1994-03-14 1998-08-25 The General Hospital Corporation Use of green porphyrins to treat neovasculature in the eye

Also Published As

Publication number Publication date
AR010754A1 (es) 2000-07-12
EP0948329A1 (en) 1999-10-13
AU5220298A (en) 1998-07-03
JP2001505885A (ja) 2001-05-08
US6043237A (en) 2000-03-28
NO992808L (no) 1999-08-09
US6248734B1 (en) 2001-06-19
AU737204B2 (en) 2001-08-09
NO992808D0 (no) 1999-06-09
WO1998025610A1 (en) 1998-06-18
CA2273010C (en) 2007-03-13
CN1246054A (zh) 2000-03-01
NZ336196A (en) 2000-10-27
ZA9711104B (en) 1998-07-10
HUP0000576A3 (en) 2002-09-30
CA2273010A1 (en) 1998-06-18
PL333951A1 (en) 2000-01-31
KR20000057510A (ko) 2000-09-15
HUP0000576A2 (hu) 2000-11-28

Similar Documents

Publication Publication Date Title
ZA9711104B (en) Use of photodynamic therapy for prevention of secondary cataracts
AU2562797A (en) Combination therapy for treatment of erectile dysfunction
GB2287652B (en) Efficient photodynamic treatment
AU5424596A (en) Microminiature illuminator for administering photodynamic therapy
EP0764030A4 (en) USE OF AUTOANTIBODIES FOR ANTI-TUMOR THERAPY AND PROPHYLAXIS
AU4411297A (en) Combination therapy for treatment of psychoses
ZA957879B (en) Combination therapy for hypercholesterolemia
AP2002002661A0 (en) Combination therapy for oesteoporosis
PL344977A1 (en) Therapeutic uses of quinoline derivatives
PL330235A1 (en) Derivatives of spiropiperidine and their application as therapeutic agents
EP1077704A4 (en) COMBINATION THERAPY FOR TREATING DEPRESSION
EP1007028A4 (en) TREATING GLAUCOMA WITH 8 ISO PROSTAGLANDINE
IL136515A0 (en) Combination effective for the treatment of impotence
EP0959879A4 (en) PHOTODYNAMIC THERAPY FOR THE TREATMENT OF ARTHROSIS
HUP9904617A3 (en) Secondary cataract inhibitor
GB9808936D0 (en) Combination therapy for the prevention and treatment of osteoporosis
AU6450398A (en) Sr-bi regulatory sequences and therapeutic methods of use
AU3118697A (en) Radiation therapy dose calculation engine
AU7105498A (en) Combination therapy for the prevention and treatment of osteoporosis
GB9725114D0 (en) Treatment of pruritus
IL135994A0 (en) Combination therapy for the treatment of aids
IL130831A0 (en) Imino-aza-anthracylinone derivatives for the treatment of amyloidosis
EP0878200A4 (en) THERAPEUTIC AGENT FOR OPHTHALMIC DISEASES
AU7985698A (en) Methods for treatment of ocular neovascularization
GB2323284B (en) Device for photodynamic therapy of pituitary tumours